Credit Suisse analyst Tiago Fauth reiterates Humanigen (NASDAQ:HGEN) with a Underperform and maintains $0.5 price target.
Credit Suisse Reiterates Underperform on Humanigen, Maintains $0.5 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.